JP2007513608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513608A5 JP2007513608A5 JP2006538786A JP2006538786A JP2007513608A5 JP 2007513608 A5 JP2007513608 A5 JP 2007513608A5 JP 2006538786 A JP2006538786 A JP 2006538786A JP 2006538786 A JP2006538786 A JP 2006538786A JP 2007513608 A5 JP2007513608 A5 JP 2007513608A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- ghrelin
- biologically active
- acid according
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03025743 | 2003-11-10 | ||
| EP03025743.0 | 2003-11-10 | ||
| PCT/EP2004/012739 WO2005049828A1 (en) | 2003-11-10 | 2004-11-10 | Nucleic acids specifically binding bioactive ghrelin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007513608A JP2007513608A (ja) | 2007-05-31 |
| JP2007513608A5 true JP2007513608A5 (https=) | 2007-12-27 |
| JP4823067B2 JP4823067B2 (ja) | 2011-11-24 |
Family
ID=34610046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538786A Expired - Fee Related JP4823067B2 (ja) | 2003-11-10 | 2004-11-10 | 生物活性グレリンに特異的に結合する核酸 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20070031840A1 (https=) |
| EP (1) | EP1682662A1 (https=) |
| JP (1) | JP4823067B2 (https=) |
| KR (1) | KR20060125743A (https=) |
| CN (1) | CN1894407A (https=) |
| AP (1) | AP2006003618A0 (https=) |
| AU (1) | AU2004291656A1 (https=) |
| BR (1) | BRPI0415872A (https=) |
| CA (1) | CA2544805A1 (https=) |
| CR (1) | CR8388A (https=) |
| EA (1) | EA009376B1 (https=) |
| EC (1) | ECSP066559A (https=) |
| IL (1) | IL175443A0 (https=) |
| MA (1) | MA28153A1 (https=) |
| NO (1) | NO20062663L (https=) |
| OA (1) | OA13282A (https=) |
| TN (1) | TNSN06132A1 (https=) |
| WO (1) | WO2005049828A1 (https=) |
| ZA (1) | ZA200603435B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1530635B1 (en) * | 2002-08-01 | 2011-06-15 | Noxxon Pharma AG | Ghrelin binding nucleic acids |
| EP2290073A3 (en) * | 2004-05-28 | 2011-08-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
| EP2302055B1 (en) | 2004-11-12 | 2014-08-27 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
| UY29460A1 (es) | 2005-04-08 | 2006-11-30 | Noxxon Pharma Ag | Acidos nucleicos de union a ghrelin |
| US20090131348A1 (en) * | 2006-09-19 | 2009-05-21 | Emmanuel Labourier | Micrornas differentially expressed in pancreatic diseases and uses thereof |
| WO2008036776A2 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
| AU2007333107A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | miR-21 regulated genes and pathways as targets for therapeutic intervention |
| AU2007333109A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Functions and targets of let-7 micro RNAs |
| WO2008073915A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Micrornas differentially expressed in leukemia and uses thereof |
| CA2671270A1 (en) * | 2006-12-29 | 2008-07-17 | Asuragen, Inc. | Mir-16 regulated genes and pathways as targets for therapeutic intervention |
| US20090232893A1 (en) * | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| US20090131354A1 (en) * | 2007-05-22 | 2009-05-21 | Bader Andreas G | miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| AU2008261951A1 (en) * | 2007-06-08 | 2008-12-18 | Asuragen, Inc. | miR-34 regulated genes and pathways as targets for therapeutic intervention |
| WO2009036332A1 (en) | 2007-09-14 | 2009-03-19 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
| WO2009052386A1 (en) * | 2007-10-18 | 2009-04-23 | Asuragen, Inc. | Micrornas differentially expressed in lung diseases and uses thereof |
| WO2009070805A2 (en) * | 2007-12-01 | 2009-06-04 | Asuragen, Inc. | Mir-124 regulated genes and pathways as targets for therapeutic intervention |
| WO2009086156A2 (en) * | 2007-12-21 | 2009-07-09 | Asuragen, Inc. | Mir-10 regulated genes and pathways as targets for therapeutic intervention |
| EP2260110B1 (en) * | 2008-02-08 | 2014-11-12 | Asuragen, INC. | miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS |
| WO2009111643A2 (en) * | 2008-03-06 | 2009-09-11 | Asuragen, Inc. | Microrna markers for recurrence of colorectal cancer |
| EP2271757A2 (en) * | 2008-03-26 | 2011-01-12 | Asuragen, INC. | Compositions and methods related to mir-16 and therapy of prostate cancer |
| WO2009137807A2 (en) | 2008-05-08 | 2009-11-12 | Asuragen, Inc. | Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
| WO2010056737A2 (en) * | 2008-11-11 | 2010-05-20 | Mirna Therapeutics, Inc. | Methods and compositions involving mirnas in cancer stem cells |
| EP2493910A1 (en) | 2009-10-30 | 2012-09-05 | Tranzyme Pharma, Inc. | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| US9976145B2 (en) | 2011-01-10 | 2018-05-22 | Noxxon Pharma Ag | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same |
| WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614395A (en) * | 1988-03-08 | 1997-03-25 | Ciba-Geigy Corporation | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof |
| ES2259800T3 (es) * | 1990-06-11 | 2006-10-16 | Gilead Sciences, Inc. | Procedimientos de uso de ligandos de acido nucleico. |
| US5780221A (en) * | 1995-05-03 | 1998-07-14 | Whitehead Institute For Biomedical Research | Identification of enantiomeric ligands |
| CA2218083A1 (en) * | 1995-05-03 | 1996-11-07 | Antonius Nicolaas Maria Schumacher | Identification of enantiomeric ligands |
| EP1286697A2 (en) * | 2000-05-17 | 2003-03-05 | Eli Lilly And Company | Method for selectively inhibiting ghrelin action |
| US20030211967A1 (en) * | 2001-05-07 | 2003-11-13 | Bryant Henry Uhlman | Method for selectively inhibiting ghrelin action |
| US6967237B2 (en) * | 2000-05-30 | 2005-11-22 | Merck & Co., Inc. | Ghrelin analogs |
| EP1530635B1 (en) * | 2002-08-01 | 2011-06-15 | Noxxon Pharma AG | Ghrelin binding nucleic acids |
| UY29460A1 (es) * | 2005-04-08 | 2006-11-30 | Noxxon Pharma Ag | Acidos nucleicos de union a ghrelin |
-
2004
- 2004-11-10 OA OA1200600147A patent/OA13282A/en unknown
- 2004-11-10 AP AP2006003618A patent/AP2006003618A0/xx unknown
- 2004-11-10 KR KR1020067009024A patent/KR20060125743A/ko not_active Withdrawn
- 2004-11-10 JP JP2006538786A patent/JP4823067B2/ja not_active Expired - Fee Related
- 2004-11-10 US US10/578,938 patent/US20070031840A1/en not_active Abandoned
- 2004-11-10 WO PCT/EP2004/012739 patent/WO2005049828A1/en not_active Ceased
- 2004-11-10 CN CNA2004800377977A patent/CN1894407A/zh active Pending
- 2004-11-10 BR BRPI0415872-5A patent/BRPI0415872A/pt not_active IP Right Cessation
- 2004-11-10 AU AU2004291656A patent/AU2004291656A1/en not_active Abandoned
- 2004-11-10 EP EP04797787A patent/EP1682662A1/en not_active Ceased
- 2004-11-10 CA CA002544805A patent/CA2544805A1/en not_active Abandoned
- 2004-11-10 EA EA200600735A patent/EA009376B1/ru not_active IP Right Cessation
-
2006
- 2006-05-02 ZA ZA200603435A patent/ZA200603435B/en unknown
- 2006-05-04 IL IL175443A patent/IL175443A0/en unknown
- 2006-05-09 TN TNP2006000132A patent/TNSN06132A1/fr unknown
- 2006-05-10 EC EC2006006559A patent/ECSP066559A/es unknown
- 2006-05-10 CR CR8388A patent/CR8388A/es not_active Application Discontinuation
- 2006-05-10 MA MA29015A patent/MA28153A1/fr unknown
- 2006-06-09 NO NO20062663A patent/NO20062663L/no not_active Application Discontinuation
-
2010
- 2010-02-24 US US12/711,415 patent/US20100261291A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007513608A5 (https=) | ||
| Jain et al. | Potential biomarkers and their applications for rapid and reliable detection of malaria | |
| Roncancio et al. | A label-free aptamer-fluorophore assembly for rapid and specific detection of cocaine in biofluids | |
| Yao et al. | Hybridization assay of hepatitis B virus by QCM peptide nucleic acid biosensor | |
| TW200844238A (en) | HLA alleles associated with adverse drug reactions and methods for detecting such | |
| CA2455731A1 (en) | Methods for evaluating pathologic conditions using extracellular rna | |
| JP2008520242A5 (https=) | ||
| JP2010516678A5 (https=) | ||
| JP2008509672A5 (https=) | ||
| JP2005130855A (ja) | インフルエンザウイルスの検出方法 | |
| JP6997709B2 (ja) | 全身性炎症反応症候群（ｓｉｒｓ）患者における合併症リスクを評価する方法 | |
| EP2683826A2 (en) | Use of aptamers in therapy and/or diagnosis of autoimmune diseases | |
| CN110004149A (zh) | 一种程序性死亡受体-配体1的核酸适体及其应用 | |
| JP2017532961A (ja) | Ｓｍａｄ７アンチセンスオリゴヌクレオチドによる対象を処置するための方法および組成物 | |
| WO2007062568A1 (en) | Compounds used as mammalian cell amp-activated protein kinase(ampk) activators and their preparation methods and usages | |
| CN112424609A (zh) | 卒中的血液生物标志物 | |
| CN104894243A (zh) | 用于肿瘤细胞检测的核酸适配体探针、装置及其应用 | |
| Wolf et al. | Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment | |
| US11634717B2 (en) | DNA aptamer specifically binding to TB7.7, and use thereof | |
| US11619633B2 (en) | DNA aptamer specifically binding to ESAT6, and use thereof | |
| WO2017148432A1 (zh) | 用于预测慢性乙肝患者对IFNα治疗的应答的方法和试剂盒 | |
| KR20140054905A (ko) | 당화혈색소에 특이적 앱타머 및 이를 포함하는 당화혈색소 검출용 조성물 | |
| JP2009511026A5 (https=) | ||
| PP et al. | Revolutionary advances in hypertension detection: Gold nanoparticle-enhanced miRNA-based electrochemical biosensors and emerging nanotechnologies | |
| WO2006080262A1 (ja) | Ａｇｅ－２アプタマー |